Ensure Your Sterile Compounding Policies Align With USP 797

January 2025

The latest USP <797> sterile compounding update includes guidance for beyond-use dates, immediate use preps, and competencies.

Be ready to implement the new standards.

Beyond-use dates (BUDs). Risk groups for sterile compounds are classified as Category 1, 2, or 3...based on where they’re prepared.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Critical Care Help Prevent TBI Complications
Obstetrics Help Conserve RhIG Supply During Nationwide Shortages
Parkinson's Disease Prevent Mishaps With Carbidopa/Levodopa Options
Pertussis Reduce Pertussis With Vaccination and Antibiotics
Immunizations Check You’re Dispensing the Right Meningococcal Vaccine
Biosimilars Brush Up on Biosimilars
Compounding Ensure Your Sterile Compounding Policies Align With USP 797
Schizophrenia Watch for Xanomeline/Trospium to Treat Schizophrenia